These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32492869)

  • 1. Development and Characterization of Liquisolid Tablets Based on Mesoporous Clays or Silicas for Improving Glyburide Dissolution.
    Cirri M; Mura P; Valleri M; Brunetti L
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32492869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and evaluation of different mesoporous silica kinds as carriers for the development of effective oral dosage forms of glibenclamide.
    Mura P; Valleri M; Fabianelli E; Maestrelli F; Cirri M
    Int J Pharm; 2019 May; 563():43-52. PubMed ID: 30926527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
    Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
    Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Development of Self-nanoemulsifying Liquisolid Tablets to Improve the Dissolution of Simvastatin.
    Elkadi S; Elsamaligy S; Al-Suwayeh S; Mahmoud H
    AAPS PharmSciTech; 2017 Oct; 18(7):2586-2597. PubMed ID: 28236269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
    Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
    Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of the coating material type and amount in the preparation of liquisolid systems based on magnesium aluminometasilicate carrier.
    Vraníková B; Svačinová P; Marushka J; Brokešová J; Holas O; Tebbens JD; Šklubalová Z
    Eur J Pharm Sci; 2021 Oct; 165():105952. PubMed ID: 34298140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suitability of various excipients as carrier and coating materials for liquisolid compacts.
    Hentzschel CM; Sakmann A; Leopold CS
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1200-7. PubMed ID: 21449826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of fast-dissolving tablet formulations of glyburide based on solid self-microemulsifying systems.
    Cirri M; Roghi A; Valleri M; Mura P
    Eur J Pharm Biopharm; 2016 Jul; 104():19-29. PubMed ID: 27091783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of dissolution rate of indomethacin: using liquisolid compacts.
    Saeedi M; Akbari J; Morteza-Semnani K; Enayati-Fard R; Sar-Reshteh-Dar S; Soleymani A
    Iran J Pharm Res; 2011; 10(1):25-34. PubMed ID: 24363677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation.
    Jaipakdee N; Limpongsa E; Sripanidkulchai BO; Piyachaturawat P
    Int J Pharm; 2018 Dec; 553(1-2):157-168. PubMed ID: 30316793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation.
    Chen B; Wang Z; Quan G; Peng X; Pan X; Wang R; Xu Y; Li G; Wu C
    Int J Nanomedicine; 2012; 7():199-209. PubMed ID: 22275835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and optimization of liquisolid compact for enhancing dissolution properties of efavirenz by using DoE approach.
    Jaydip B; Dhaval M; Soniwala MM; Chavda J
    Saudi Pharm J; 2020 Jun; 28(6):737-745. PubMed ID: 32550806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Investigation into the Influence of Process Parameters and Formulation Variables on Compaction Properties of Liquisolid Systems.
    Aleksić I; German Ilić I; Cvijić S; Parojčić J
    AAPS PharmSciTech; 2020 Aug; 21(7):242. PubMed ID: 32839881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of flowable liquid retention potential of aluminometasilicate carrier for liquisolid systems preparation.
    Vraníková B; Gajdziok J; Vetchý D
    Pharm Dev Technol; 2015 Nov; 20(7):839-844. PubMed ID: 24927105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of griseofulvin release from liquisolid compacts.
    Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS
    Eur J Pharm Biopharm; 2012 Jan; 80(1):130-5. PubMed ID: 21846502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro release evaluation of hydrocortisone liquisolid tablets.
    Spireas S; Sadu S; Grover R
    J Pharm Sci; 1998 Jul; 87(7):867-72. PubMed ID: 9649356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquisolid systems to improve the dissolution of furosemide.
    Akinlade B; Elkordy AA; Essa EA; Elhagar S
    Sci Pharm; 2010; 78(2):325-44. PubMed ID: 21179350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of powder substrate on the dissolution properties of methyclothiazide liquisolid compacts.
    Spireas S; Wang T; Grover R
    Drug Dev Ind Pharm; 1999 Feb; 25(2):163-8. PubMed ID: 10065349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New solid self-microemulsifying systems to enhance dissolution rate of poorly water soluble drugs.
    Mura P; Valleri M; Cirri M; Mennini N
    Pharm Dev Technol; 2012; 17(3):277-84. PubMed ID: 21108583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
    Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
    Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.